Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.

NCT03254420 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DEVICE: Calypso beacon implant
RADIATION: moderate hypofractionation Radiotherapy

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle